Electromyography and Nerve Conduction Velocity Testing

Introduction to EMG-NCV Testing

Electromyography (EMG) involves inserting a needle electrode into a muscle and recording the electrical activity at rest and during muscle contraction, showing motor unit potentials or motor unit action potentials, as recommended by the American Thoracic Society 1, 2
Nerve Conduction Studies (NCS) or Nerve Conduction Velocity (NCV) involves providing an electrical stimulus to a nerve and recording the electrical response from a sensory nerve or muscle, with guidelines supported by the American Academy of Neurology 1

EMG-NCV helps elucidate the etiology of muscle weakness by differentiating between various neurological and muscular causes, according to the American College of Chest Physicians 1
The tests can detect abnormalities in muscle diseases (myopathies), as stated by the American College of Rheumatology 3
EMG-NCV can also detect motor neuron diseases, as reported by the American Academy of Otolaryngology-Head and Neck Surgery 4

Severity assessment: Quantifies the degree of nerve or muscle damage, as measured by the American College of Chest Physicians 1
EMG-NCV can differentiate between botulism, myasthenia gravis, and Guillain-Barré syndrome, as recommended by the Centers for Disease Control and Prevention 5, 6
Critical illness polyneuropathy in ICU patients can be diagnosed using EMG-NCV, according to the Society of Critical Care Medicine 1, 3

Respiratory muscle weakness: Assessing diaphragmatic function in patients with breathing difficulties, as evaluated by the American Thoracic Society 3, 7
Laryngeal disorders: Helps diagnose neurological causes of voice and swallowing problems, as reported by the American Academy of Otolaryngology-Head and Neck Surgery 4, 8

Botulism: Shows increment in compound motor nerve action potential amplitude with repetitive nerve stimulation at 30-50 Hz, decreased recruitment of muscle units, and decreased motor-evoked amplitude, as described by the Centers for Disease Control and Prevention 5, 6
ICU-acquired weakness: Can detect critical illness polyneuropathy/myopathy before clinical examination is possible in sedated or uncooperative patients, according to the Society of Critical Care Medicine 1, 2

Timing matters: Early in disease processes (like botulism), results may be normal or almost normal, as stated by the Centers for Disease Control and Prevention 5, 9
Technical challenges: Tests are operator-dependent, require specialized training and equipment, and take approximately 2 hours to complete, as reported by the Centers for Disease Control and Prevention 5, 6
Patient cooperation: Full EMG examination requires patient cooperation, which may be difficult in severely ill or pediatric patients, as noted by the Centers for Disease Control and Prevention 6
Interpretation complexity: Results require expert interpretation and should always be considered in the context of clinical, epidemiologic, and laboratory data, as recommended by the Centers for Disease Control and Prevention 9
Discomfort: The examination can be painful, especially repetitive nerve stimulation at high frequencies, as reported by the Centers for Disease Control and Prevention 6